F

Fundacion CENIT | Buenos Aires, Argentina

Research site

(Unclaimed)

Location

Juncal 2222 PB, Buenos Aires, Buenos Aires, Argentina

Site insights

Top conditions

Top treatments

Trastuzumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

Locations recently updated

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

This is a double-blind, randomized, multiregion, comparative phase Ⅲ clinical study designed to evaluate the efficacy and safety of HLX22 in combinat...

Enrolling

Gastric Cancer

Monoclonal Antibody

Drug: HLX22

Drug: Pembrolizumab

Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)

This study will evaluate the efficacy and safety of trastuzumab deruxtecan (T-DXd) compared with ramucirumab and paclitaxel (Ram + PTX) in participan...

Active, not recruiting

Gastric Cancer, Adenocarcinoma

Gastroesophageal Junction Adenocarcinoma

Drug: Ramucirumab

Drug: Paclitaxel

Trial sponsors

H

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms